Additionally, a body of research has demonstrated that CD133 serves as a valuable independent prognostic indicator in individuals with colorectal cancer, with higher levels of CD133 expression being associated with advanced tumor stages and liver metastasis.29, 30. The gene discussed is PROM1; the disease is colorectal cancer.